Xia Yu

1.2k total citations
54 papers, 860 citations indexed

About

Xia Yu is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Xia Yu has authored 54 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 35 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Xia Yu's work include Tuberculosis Research and Epidemiology (39 papers), Mycobacterium research and diagnosis (32 papers) and Antibiotic Resistance in Bacteria (7 papers). Xia Yu is often cited by papers focused on Tuberculosis Research and Epidemiology (39 papers), Mycobacterium research and diagnosis (32 papers) and Antibiotic Resistance in Bacteria (7 papers). Xia Yu collaborates with scholars based in China, Switzerland and United States. Xia Yu's co-authors include Hairong Huang, Hairong Huang, Lingling Dong, Guanglu Jiang, Jingjing Luo, Yunxu Li, Yifeng Ma, Liping Zhao, Fen Wang and Guan Liu and has published in prestigious journals such as PLoS ONE, Analytical Chemistry and Scientific Reports.

In The Last Decade

Xia Yu

51 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xia Yu China 17 519 480 259 177 94 54 860
Krishnamoorthy Gopinath India 18 528 1.0× 473 1.0× 213 0.8× 178 1.0× 107 1.1× 28 770
Л. Н. Черноусова Russia 18 661 1.3× 593 1.2× 298 1.2× 223 1.3× 37 0.4× 89 1.0k
Yaoju Tan China 21 934 1.8× 761 1.6× 445 1.7× 243 1.4× 73 0.8× 61 1.2k
Haiqing Chu China 20 476 0.9× 577 1.2× 166 0.6× 74 0.4× 191 2.0× 74 1.1k
Jun Yue China 21 667 1.3× 554 1.2× 328 1.3× 220 1.2× 51 0.5× 50 1.1k
JoLynn Troudt United States 17 823 1.6× 619 1.3× 308 1.2× 166 0.9× 39 0.4× 24 1.2k
Anita G. Amin United States 15 542 1.0× 463 1.0× 428 1.7× 145 0.8× 19 0.2× 29 959
Jan Heyckendorf Germany 19 887 1.7× 703 1.5× 195 0.8× 350 2.0× 45 0.5× 55 1.1k
Ram Das India 18 452 0.9× 450 0.9× 207 0.8× 213 1.2× 52 0.6× 65 869
Fengmin Huo China 19 908 1.7× 697 1.5× 224 0.9× 434 2.5× 64 0.7× 59 1.2k

Countries citing papers authored by Xia Yu

Since Specialization
Citations

This map shows the geographic impact of Xia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Yu more than expected).

Fields of papers citing papers by Xia Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Yu. The network helps show where Xia Yu may publish in the future.

Co-authorship network of co-authors of Xia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xia Yu. A scholar is included among the top collaborators of Xia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xia Yu. Xia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Wu, Jing, et al.. (2024). Bedaquiline susceptibility testing of Mycobacterium abscessus complex and Mycobacterium avium complex: A meta-analysis study. Journal of Global Antimicrobial Resistance. 37. 135–140. 2 indexed citations
4.
Jiang, Xiaoyi, et al.. (2024). Nontuberculous mycobacterial disease in children: A systematic review and meta-analysis. Heliyon. 10(11). e31757–e31757. 1 indexed citations
5.
Huang, Hairong, et al.. (2023). Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs. Frontiers in Cellular and Infection Microbiology. 13. 1243457–1243457. 9 indexed citations
6.
Yu, Xia, Fen Wang, Lingling Dong, et al.. (2023). Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum. Microbiology Spectrum. 11(4). e0126523–e0126523. 4 indexed citations
7.
Yu, Xia, et al.. (2022). Xpert MTB/RIF Ultra outperformed the Xpert assay in tuberculosis lymphadenitis diagnosis: a prospective head-to-head cohort study. International Journal of Infectious Diseases. 122. 741–746. 7 indexed citations
8.
Wang, Guirong, Guanglu Jiang, Wei Jing, et al.. (2021). Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey. Journal of Infection. 82(3). 371–377. 22 indexed citations
9.
Wen, Shu’an, Xiaopan Gao, Fengmin Huo, et al.. (2021). Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China. International Journal of Infectious Diseases. 109. 253–260. 21 indexed citations
10.
Zhou, Zhen, Chenghai Li, Tao Liu, et al.. (2020). Combination of Percutaneous Lung Biopsy and Xpert MTB/RIF Ultra Enhances the Differential Diagnosis of Tuberculosis: A Prospective Cohort Study. Infectious Diseases and Therapy. 9(4). 797–806. 7 indexed citations
11.
Gao, Xiaopan, Zhixia Mu, Xia Yu, et al.. (2018). Structural Insight Into Conformational Changes Induced by ATP Binding in a Type III Secretion-Associated ATPase From Shigella flexneri. Frontiers in Microbiology. 9. 1468–1468. 15 indexed citations
12.
Yu, Xia, Guirong Wang, Suting Chen, et al.. (2016). Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin. Antimicrobial Agents and Chemotherapy. 60(9). 5232–5237. 18 indexed citations
13.
Yu, Xia, Guan Liu, Liping Zhao, et al.. (2016). The prevalence of non-tuberculous mycobacterial infections in mainland China: Systematic review and meta-analysis. Journal of Infection. 73(6). 558–567. 77 indexed citations
14.
Yu, Xia, Guanglu Jiang, Yifeng Ma, et al.. (2016). Evaluation of a High-Intensity Green Fluorescent Protein Fluorophage Method for Drug- Resistance Diagnosis in Tuberculosis for Isoniazid, Rifampin, and Streptomycin. Frontiers in Microbiology. 7. 922–922. 6 indexed citations
15.
Li, Xuming, Yongqiang Zhu, Xia Yu, et al.. (2015). Genomic Analysis of a Mycobacterium Bovis Bacillus Calmette-Guérin Strain Isolated from an Adult Patient with Pulmonary Tuberculosis. PLoS ONE. 10(4). e0122403–e0122403. 5 indexed citations
16.
Liu, Guan, et al.. (2015). Bacteriological and virulence study of a Mycobacterium chimaera isolate from a patient in China. Antonie van Leeuwenhoek. 107(4). 901–909. 8 indexed citations
17.
Liu, Guan, Guirong Wang, Xia Yu, et al.. (2014). Bacteriological characterization of a Mycobacterium parascrofulaceum strain isolated from a Chinese pneumonia patient. International Journal of Infectious Diseases. 25. 82–87. 4 indexed citations
18.
Xie, Longxiang, Xiaobo Wang, Jie Zeng, et al.. (2014). Proteome-wide lysine acetylation profiling of the human pathogen Mycobacterium tuberculosis. The International Journal of Biochemistry & Cell Biology. 59. 193–202. 126 indexed citations
19.
Du, Qinglin, Guangming Dai, Quanxin Long, et al.. (2013). Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. Diagnostic Microbiology and Infectious Disease. 77(2). 138–142. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026